[DNLI] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
27-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -16.79%
YoY- -169.68%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 9,393 5,847 3,604 4,672 13,604 4,197 4,205 70.63%
PBT -58,172 -58,679 -56,898 -53,950 -46,373 -58,650 -38,992 30.46%
Tax 56 79 -135 75 -113 -313 0 -
NP -58,228 -58,758 -56,763 -54,025 -46,260 -58,337 -38,992 30.55%
Tax Rate - - - - - - - -
Total Cost 67,621 64,605 60,367 58,697 59,864 62,534 43,197 34.70%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -619.91 -1,004.93 -1,575.00 -1,156.36 -340.05 -1,389.97 -927.28 -23.48%
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -0.54 -0.56 -0.55 -0.57 -0.48 -0.61 -0.41 20.09%
EPS Diluted -0.54 -0.56 -0.55 -0.56 -0.48 -0.61 -0.41 20.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.